Home›Companies›Biotech & Pharma›Panome Bio

Panome Bio Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 21, 2024·Suggest an edit

About Panome Bio

Panome Bio is a private company based in Saint Louis, Missouri, incorporated in 2022 in Delaware. It has reported $11,973,835 raised in two offerings on Form D since February 2023. Its chief executive is Edward Weinstein.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 14, 2024Nov 21, 2024$6,000,000fully sold6$1.0MEquityRule 506(b)Form D ↗
Feb 15, 2023Feb 24, 2023$5,973,835fully sold6$995KEquityRule 506(b)Form D ↗
Total, two offerings$11,973,835

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Panome Bio's Form D filed Nov 21, 2024.

DS
TC
Tom Cohen
Executive officer
RC
Rob Capone
Director
Also a director at Cell Microsystems.
EW
Edward Weinstein
Chief Executive Officer and director
DL
Deval Lashkari
Director
Also a director at Cell Microsystems.

Earlier filings also listed Alexander Herzick (director, last listed Feb 2023).

Sources

  1. SECPanome Bio Inc. filing history